We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MAMK:NASDAQMaxsMaking Inc. Analysis

Data as of 2026-04-16 - not real-time

$13.16

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

MaxsMaking Inc. trades at $13.16, essentially flat on its 20‑day and 50‑day SMAs, but the RSI of 80.8 signals an overbought condition and the MACD histogram is negative, indicating bearish momentum. The stock’s valuation is stretched, with a trailing P/E of 219 versus an industry average of about 31 and a price‑to‑book of 17.8, suggesting the market is pricing in unrealistic growth expectations. Despite a robust revenue growth rate of 44%, margins are thin (gross margin < 9%) and the company is burning cash, posting negative operating and free cash flow of over $5 million and $4.5 million respectively. Debt is a major concern: total debt exceeds $4.3 million while cash sits at only $0.14 million, yielding a debt‑to‑equity ratio above 34. The Extreme Greed sentiment on the Fear & Greed Index adds a speculative flavor, but the underlying fundamentals are weak, and the stock faces a potential pull‑back toward its $13 support level.
Given the near‑zero beta and negligible reported volatility, price movements are likely driven by company‑specific news rather than market swings, and the high debt load combined with negative cash flows raises significant downside risk. The lack of a dividend and the absence of analyst coverage further limit upside catalysts. Investors should treat the current price as precariously valued and consider reducing exposure unless a clear turnaround in cash generation materializes.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Overbought RSI above 80
  • Bearish MACD divergence
  • Valuation far above industry multiples

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strong revenue growth but thin margins
  • High debt burden limiting flexibility
  • Negative cash flow trends

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Sustained overvaluation with no earnings improvement
  • Elevated debt‑to‑equity and cash burn
  • Exposure to Chinese regulatory and geopolitical risks

Key Metrics & Analysis

Financial Health

Revenue Growth43.70%
Profit Margin0.01%
P/E Ratio219.3
ROE0.17%
ROA0.33%
Debt/Equity34.30
P/B Ratio17.8
Op. Cash Flow$-5285745
Free Cash Flow$-4540143
Industry P/E30.9

Technical Analysis

TrendNeutral
RSI80.8
Support$13.00
Resistance$13.00
MA 20$13.00
MA 50$13.00
MA 200$8.42
MACDBearish
VolumeStable
Fear & Greed Index88.98

Valuation

GradeOvervalued
TypeBlend

Risk Assessment

Beta-0.08
0
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.